文献速递系统性红斑狼疮

SLE遗传与转录组联合分析:易感性和严重性的靶向特征

Combined genetic and transcriptome analysis of patients with SLE: distinct, targetable signatures for susceptibility and severity.
PubMed 文献 · Ann Rheum Dis · 2019-06-05

研究对142例SLE患者和58名健康志愿者的血液进行mRNA测序和基因分型,识别出易感性、活动性和严重性三种基因特征,DEG分类器诊断SLE中位敏感度86%、特异度92%,转录组指数可区分活动与非活动疾病并与严重性相关。

要点

  • SLE存在易感性、活动性和严重性三种可靶向的基因特征。
  • DEG分类器区分SLE与健康人中位敏感度86%、特异度92%。
  • 转录组指数可区分活动与非活动疾病,但不区分低疾病活动度。

核心结论

  • 特定基因网络分别赋予SLE易感性、活动性和严重性,可能促进个性化诊疗。

研究设计与样本

  • 对142例SLE患者和58名健康志愿者的血液进行mRNA测序和基因分型。

主要发现

  • SLE存在临床缓解期仍存在的易感性特征、与免疫细胞代谢和增殖基因相关的活动性特征、以及富集可成药粒细胞和浆母细胞/浆细胞通路的严重性特征。
  • SLE患者mRNA剪接 perturbed,富集于免疫系统和干扰素信号基因。
  • DEG分类器区分SLE与健康人中位敏感度86%、特异度92%。
  • 转录组指数区分活动与非活动疾病但不区分低疾病活动度,并与疾病严重性相关。

关键数值与推荐

  • DEG分类器在80%数据集训练、20%验证中运行1000次迭代,区分SLE与健康人中位敏感度86%、特异度92%。

临床怎么用

  • 转录组指数可用于区分SLE活动与非活动疾病并关联严重性。
  • DEG分类器可能用于SLE诊断辅助。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Systemic lupus erythematosus (SLE) diagnosis and treatment remain empirical and the molecular basis for its heterogeneity elusive. We explored the genomic basis for disease susceptibility and severity. METHODS: mRNA sequencing and genotyping in blood from 142 patients with SLE and 58 healthy volunteers. Abundances of cell types were assessed by CIBERSORT and cell-specific effects by interaction terms in linear models. Differentially expressed genes (DEGs) were used to train classifiers (linear discriminant analysis) of SLE versus healthy individuals in 80% of the dataset and were validated in the remaining 20% running 1000 iterations. Transcriptome/genotypes were integrated by expression-quantitative trail loci (eQTL) analysis; tissue-specific genetic causality was assessed by regulatory trait concordance (RTC). RESULTS: SLE has a 'susceptibility signature' present in patients in clinical remission, an 'activity signature' linked to genes that regulate immune cell metabolism, protein synthesis and proliferation, and a 'severity signature' best illustrated in active nephritis, enriched in druggable granulocyte and plasmablast/plasma-cell pathways. Patients with SLE have also perturbed mRNA splicing enriched in immune system and interferon signalling genes. A novel transcriptome index distinguished active versus inactive disease-but not low disease activity-and correlated with disease severity. DEGs discriminate SLE versus healthy individuals with median sensitivity 86% and specificity 92% suggesting a potential use in diagnostics. Combined eQTL analysis from the Genotype Tissue Expression (GTEx) project and SLE-associated genetic polymorphisms demonstrates that susceptibility variants may regulate gene expression in the blood but also in other tissues. CONCLUSION: Specific gene networks confer susceptibility to SLE, activity and severity, and may facilitate personalised care.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Panousis NI, Bertsias GK, Ongen H, et al. Combined genetic and transcriptome analysis of patients with SLE: distinct, targetable signatures for susceptibility and severity. Ann Rheum Dis. 2019. PMID: 31167757. doi:10.1136/annrheumdis-2018-214379

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。